Treatment of Acute Schizophrenia With Vitamin Therapy
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
Controlled studies using the orthomolecular approach have been few (Deutsch, Ananth, & Ban,
1977). Those that were done were performed in chronic schizophrenia or in populations that
included bipolar and schizoaffective patients. Both of these diagnostic groups are not today
considered to benefit from the orthomolecular approach. Moreover, some negative studies of
high-dose niacin were done in patients who were not otherwise given general counseling for
good diet as described above. Therefore, this proposal is to study in a controlled manner
carefully defined first onset schizophrenic patients using the protocol advocated by Osmond
and Hoffer (1962). Patients can enter the study if they have been ill less than 1 year and
are in their first hospitalization.
Phase:
Phase 4
Details
Lead Sponsor:
Beersheva Mental Health Center
Collaborators:
International Schizophrenia Foundation Supported by a Hilton Family Foundation grant to
Treatments:
Niacin Niacinamide Nicotinic Acids Pyridoxal Pyridoxine Vitamin B 6